Role of the p53-homologue p73 in E2F1-induced apoptosis (original) (raw)

References

  1. Sherr, C.J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984–2991 (1998).
    Article CAS Google Scholar
  2. Phillips, A.C., Bates, S., Ryan, K.M., Helin, K. & Vousden, K.H. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11, 1853–1863 ( 1998).
    Article Google Scholar
  3. Bates, S. et al. p14ARF links the tumor suppressors RB and p53. Nature 395, 124–125 ( 1998).
    Article CAS Google Scholar
  4. Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424–2433 (1998).
    Article CAS Google Scholar
  5. Kaghad, M. et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90, 809–819 ( 1997).
    Article CAS Google Scholar
  6. Jost, C.A., Marin, M.C. & Kaelin, W.G. p73 is a human p53-related protein that can induce apoptosis. Nature 389, 191– 194 (1997).
    Article CAS Google Scholar
  7. Zhu, J., Jiang, J., Zhou, W. & Chen, X. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 58, 5061–5068 (1998).
    CAS PubMed Google Scholar
  8. Vigo, E. et al. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol. Cell. Biol. 19, 6379–6395 (1999).
    Article CAS Google Scholar
  9. Zeng, X. et al. The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis. Mol. Cell. Biol. 20, 1299–1310 (2000).
    Article CAS Google Scholar
  10. Di Como, C.J., Gaiddon, C. & Prives, C. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol. Cell. Biol. 19 , 1438–1449 (1999).
    Article CAS Google Scholar
  11. Marin, M.C. et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nature Genet. 25, 47– 54 (2000).
    Article CAS Google Scholar
  12. Phillips, A.C. et al. E2F-1 potentiates cell death by blocking anti-apoptotic signaling pathways. Mol. Cell 4, 771– 781 (1999).
    Article CAS Google Scholar
  13. Kovalev, S. et al. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ. 9, 897–903 ( 1998).
    CAS PubMed Google Scholar
  14. Yokomizo, A. et al. Overexpression of the wild type p73 gene in human bladder cancer. Oncogene 18, 1625– 1629 (1999).
    Article Google Scholar
  15. Ng, S.-W. et al. Analysis of p73 in human borderline and invasive ovarian tumor . Oncogene 19, 1885–1890 (2000).
    Article CAS Google Scholar
  16. Helin, K., Harlow, E. & Fattaey, A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13, 6501–6508 (1993).
    Article CAS Google Scholar
  17. Cress, W.D., Johnson, D.G. & Nevins, J.R. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol. Cell. Biol. 13, 6314–6325 (1993).
    Article CAS Google Scholar
  18. Lee, T.A. & Farnham, P.J. Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation. Oncogene 19, 2257–2268 ( 2000).
    Article CAS Google Scholar
  19. Baker, S.J., Markowitz, S., Fearon, E., Willson, B. & Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249 , 912–915 (1990).
    Article CAS Google Scholar
  20. DeLaurenzi, V. et al. Two new p73 splice variants, γ and δ, with different transcriptional activity. J. Exp. Med. 188, 1763–1768 (1998).
    Article CAS Google Scholar
  21. Pützer, B.M., Stiewe, T., Crespo, F. & Esche, H. Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy. Gene Ther. 7 , 1317–1325 (2000).
    Article Google Scholar
  22. Kalejta, R.F., Shenk, T. & Beavis, A.J. Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry. Cytometry 29, 286–291 (1997).
    Article CAS Google Scholar
  23. de Stanchina, E. et al. E1A signaling to p53 involves the p19ARF tumor suppressor . Genes Dev. 12, 2434–2442 (1998).
    Article CAS Google Scholar
  24. Van den Hoff, M.J.B., Moorman, A.F.M. & Lamers, W.H. Electroporation intracellular buffer increases cell survival. Nucleic Acids Res. 20, 2902 (1992).
    Article CAS Google Scholar
  25. Chiang, S.-Y., Azizkhan, J.C. & Beerman, T.A. A comparison of DNA-binding drugs as inhibitors of E2F1- and Sp1-DNA complexes and associated gene expression. Biochemistry 37, 3109–3115 (1998).
    Article CAS Google Scholar
  26. Wu, K.-J. et al. Direct activation of TERT transcription by c-MYC. Nature Genet. 21, 220–224 (1999).
    Article CAS Google Scholar
  27. Marin, M.C. et al. Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol. Cell. Biol. 18, 6316– 6324 (1998).
    Article CAS Google Scholar
  28. Ormerod, M.G., Sun, X.-M., Brown, D., Snowden, R.T. & Cohen, G.M. Quantification of apoptosis and necrosis by flow cytometry. Acta Oncol. 32, 417–424 (1993).
    Article CAS Google Scholar

Download references